Treatment adherence in patients with type 2 diabetes mellitus correlates with different coping styles, low perception of self-influence on disease, and depressive symptoms

Andrzej Kokoszka1,2 1II Department of Psychiatry, Medical University of Warsaw, 2Department of Psychology, SWPS University of Social Sciences and Humanities, Warsaw, Poland Background: Insulin analogs are regarded as more convenient to use than human insulin; however, they require a different admi...

Full description

Bibliographic Details
Main Author: Kokoszka A
Format: Article
Language:English
Published: Dove Medical Press 2017-03-01
Series:Patient Preference and Adherence
Subjects:
Online Access:https://www.dovepress.com/treatment-adherence-in-patients-with-type-2-diabetes-mellitus-correlat-peer-reviewed-article-PPA
_version_ 1818683680420265984
author Kokoszka A
author_facet Kokoszka A
author_sort Kokoszka A
collection DOAJ
description Andrzej Kokoszka1,2 1II Department of Psychiatry, Medical University of Warsaw, 2Department of Psychology, SWPS University of Social Sciences and Humanities, Warsaw, Poland Background: Insulin analogs are regarded as more convenient to use than human insulin; however, they require a different administration scheme due to their unique pharmacokinetic and pharmacodynamic properties. This study aimed to assess difficulties with adherence to treatment with insulin analogs in patients with type 2 diabetes mellitus (T2DM), who had previously been treated with human insulin. The associations between difficulties with adherence and clinical, demographic, and psychological characteristics were also evaluated.Patients and methods: The study was conducted on 3,467 consecutively enrolled patients with T2DM (54.4% women), mean age 63.9 years (SD =9.57), who had recently undergone a physician-directed change in treatment from human insulin to insulin analogs. The questionnaires addressed difficulties with switching the therapy, coping styles, well-being, and perception of self-influence on the disease.Results: No adherence problems in switching therapy were reported in 56.6% of patients. Specific moderate difficulties were reported in 10.4%–22.1% of patients, major difficulties in 0.7%–6.9% of patients, and very significant difficulties in 0.03%–1.3% of patients. Overall, remembering to modify the insulin dose in the case of additional meals was the most frequently reported difficulty, and problems with identifying hypoglycemic symptoms were the least frequently reported. The increased risk of difficulties was moderately related to low perception of self-influence on diabetes and poor well-being. The intensity of problems was higher among those who were less-educated, lived in rural areas, had complications, and/or reported maladaptive coping styles.Conclusion: Switching from human insulin to an insulin analog did not cause adherence problems in more than half of the patients. In the remaining patients, difficulties in adherence correlated with maladaptive coping styles, low perception of self-influence on disease course, and depressive symptoms. Keywords: adherence, type 2 diabetes mellitus, insulin, insulin analogs, treatment adherence
first_indexed 2024-12-17T10:38:35Z
format Article
id doaj.art-25d6a5800ffa42859fa5b5aceb3280ef
institution Directory Open Access Journal
issn 1177-889X
language English
last_indexed 2024-12-17T10:38:35Z
publishDate 2017-03-01
publisher Dove Medical Press
record_format Article
series Patient Preference and Adherence
spelling doaj.art-25d6a5800ffa42859fa5b5aceb3280ef2022-12-21T21:52:18ZengDove Medical PressPatient Preference and Adherence1177-889X2017-03-01Volume 1158759531934Treatment adherence in patients with type 2 diabetes mellitus correlates with different coping styles, low perception of self-influence on disease, and depressive symptomsKokoszka AAndrzej Kokoszka1,2 1II Department of Psychiatry, Medical University of Warsaw, 2Department of Psychology, SWPS University of Social Sciences and Humanities, Warsaw, Poland Background: Insulin analogs are regarded as more convenient to use than human insulin; however, they require a different administration scheme due to their unique pharmacokinetic and pharmacodynamic properties. This study aimed to assess difficulties with adherence to treatment with insulin analogs in patients with type 2 diabetes mellitus (T2DM), who had previously been treated with human insulin. The associations between difficulties with adherence and clinical, demographic, and psychological characteristics were also evaluated.Patients and methods: The study was conducted on 3,467 consecutively enrolled patients with T2DM (54.4% women), mean age 63.9 years (SD =9.57), who had recently undergone a physician-directed change in treatment from human insulin to insulin analogs. The questionnaires addressed difficulties with switching the therapy, coping styles, well-being, and perception of self-influence on the disease.Results: No adherence problems in switching therapy were reported in 56.6% of patients. Specific moderate difficulties were reported in 10.4%–22.1% of patients, major difficulties in 0.7%–6.9% of patients, and very significant difficulties in 0.03%–1.3% of patients. Overall, remembering to modify the insulin dose in the case of additional meals was the most frequently reported difficulty, and problems with identifying hypoglycemic symptoms were the least frequently reported. The increased risk of difficulties was moderately related to low perception of self-influence on diabetes and poor well-being. The intensity of problems was higher among those who were less-educated, lived in rural areas, had complications, and/or reported maladaptive coping styles.Conclusion: Switching from human insulin to an insulin analog did not cause adherence problems in more than half of the patients. In the remaining patients, difficulties in adherence correlated with maladaptive coping styles, low perception of self-influence on disease course, and depressive symptoms. Keywords: adherence, type 2 diabetes mellitus, insulin, insulin analogs, treatment adherencehttps://www.dovepress.com/treatment-adherence-in-patients-with-type-2-diabetes-mellitus-correlat-peer-reviewed-article-PPAadherencetype 2 diabetes mellitusinsulininsulin analogstreatment adherence
spellingShingle Kokoszka A
Treatment adherence in patients with type 2 diabetes mellitus correlates with different coping styles, low perception of self-influence on disease, and depressive symptoms
Patient Preference and Adherence
adherence
type 2 diabetes mellitus
insulin
insulin analogs
treatment adherence
title Treatment adherence in patients with type 2 diabetes mellitus correlates with different coping styles, low perception of self-influence on disease, and depressive symptoms
title_full Treatment adherence in patients with type 2 diabetes mellitus correlates with different coping styles, low perception of self-influence on disease, and depressive symptoms
title_fullStr Treatment adherence in patients with type 2 diabetes mellitus correlates with different coping styles, low perception of self-influence on disease, and depressive symptoms
title_full_unstemmed Treatment adherence in patients with type 2 diabetes mellitus correlates with different coping styles, low perception of self-influence on disease, and depressive symptoms
title_short Treatment adherence in patients with type 2 diabetes mellitus correlates with different coping styles, low perception of self-influence on disease, and depressive symptoms
title_sort treatment adherence in patients with type 2 diabetes mellitus correlates with different coping styles low perception of self influence on disease and depressive symptoms
topic adherence
type 2 diabetes mellitus
insulin
insulin analogs
treatment adherence
url https://www.dovepress.com/treatment-adherence-in-patients-with-type-2-diabetes-mellitus-correlat-peer-reviewed-article-PPA
work_keys_str_mv AT kokoszkaa treatmentadherenceinpatientswithtype2diabetesmellituscorrelateswithdifferentcopingstyleslowperceptionofselfinfluenceondiseaseanddepressivesymptoms